GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (NSE:ORCHPHARMA) » Definitions » Other Operating Expense

Orchid Pharma (NSE:ORCHPHARMA) Other Operating Expense : ₹2,017 Mil (TTM As of Mar. 2025)


View and export this data going back to 1997. Start your Free Trial

What is Orchid Pharma Other Operating Expense?

Orchid Pharma's Other Operating Expense for the three months ended in Mar. 2025 was ₹311 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₹2,017 Mil.

Orchid Pharma's quarterly Other Operating Expense declined from Sep. 2024 (₹698 Mil) to Dec. 2024 (₹307 Mil) but then increased from Dec. 2024 (₹307 Mil) to Mar. 2025 (₹311 Mil).

Orchid Pharma's annual Other Operating Expense declined from Mar. 2023 (₹2,096 Mil) to Mar. 2024 (₹635 Mil) but then increased from Mar. 2024 (₹635 Mil) to Mar. 2025 (₹1,209 Mil).


Orchid Pharma Other Operating Expense Historical Data

The historical data trend for Orchid Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Pharma Other Operating Expense Chart

Orchid Pharma Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,285.27 2,281.89 2,095.69 635.02 1,209.06

Orchid Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 251.41 701.04 698.25 306.63 311.14

Orchid Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,017 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orchid Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Orchid Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Orchid Pharma Business Description

Traded in Other Exchanges
Address
Sector 74A, 15th Floor, Tower-1, DLF Corporate Greens, Narsinghpur, Gurugram, HR, IND, 122004
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Cephalosporin Pharmaceuticals, in which the Company drives its major sales through Active Pharmaceuticals Ingredients. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma Headlines

No Headlines